MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciac613

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.

Vihta Karina Doris, Pouwels Koen B, Peto Tim Ea, Pritchard Emma, House Thomas, Studley Ruth, Rourke Emma, Cook Duncan, Diamond Ian, Crook Derrick, Clifton David A, Matthews Philippa C, Stoesser Nicole, Eyre David W, Walker Ann Sarah, COVID-19 Infection Survey team

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The SARS-CoV-2 Delta variant has been replaced by the highly transmissible Omicron BA.1 variant, and subsequently by Omicron BA.2. It is important to understand how these changes in dominant variants affect reported symptoms, while also accounting for symptoms arising from other co-circulating respiratory viruses.

METHODS

In a nationally representative UK community study, the COVID-19 Infection Survey, we investigated symptoms in PCR-positive infection episodes vs. PCR-negative study visits over calendar time, by age and vaccination status, comparing periods when the Delta, Omicron BA.1 and BA.2 variants were dominant.

RESULTS

Between October-2020 and April-2022, 120,995 SARS-CoV-2 PCR-positive episodes occurred in 115,886 participants, with 70,683 (58%) reporting symptoms. The comparator comprised 4,766,366 PCR-negative study visits (483,894 participants); 203,422 (4%) reporting symptoms. Symptom reporting in PCR-positives varied over time, with a marked reduction in loss of taste/smell as Omicron BA.1 dominated, maintained with BA.2 (44%/45% 17 October 2021, 16%/13% 2 January 2022, 15%/12% 27 March 2022). Cough, fever, shortness of breath, myalgia, fatigue/weakness and headache also decreased after Omicron BA.1 dominated, but sore throat increased, the latter to a greater degree than concurrent increases in PCR-negatives. Fatigue/weakness increased again after BA.2 dominated, although to a similar degree to concurrent increases in PCR-negatives. Symptoms were consistently more common in adults aged 18-65 years than in children or older adults.

CONCLUSIONS

Increases in sore throat (also common in the general community), and a marked reduction in loss of taste/smell, make Omicron harder to detect with symptom-based testing algorithms, with implications for institutional and national testing policies.

Для цитирования: Vihta Karina Doris, Pouwels Koen B, Peto Tim Ea, Pritchard Emma, House Thomas, Studley Ruth, Rourke Emma, Cook Duncan, Diamond Ian, Crook Derrick, Clifton David A, Matthews Philippa C, Stoesser Nicole, Eyre David W, Walker Ann Sarah, COVID-19 Infection Survey team. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022. DOI: 10.1093/cid/ciac613.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.